Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,411
The Myelin Disorders Biorepository Project
for
Leukodystrophy, White Matter Disease, Leukoencephalopathies,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT03047369
Recruiting
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
for
Peripheral Arterial Diseases
Location: Baltimore MD, Chapel Hill NC, Cleveland OH, Boston MA,
Sponsor: Angiodynamics, Inc.
Sex: All
Age: 0+
Code: NCT06777901
Recruiting
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
for
Sickle Cell Disease
Location: Bethesda MD
Sponsor: National Human Genome Research Institute (NHGRI)
Sex: All
Age: 2 - 70+
Code: NCT06944067
Recruiting
Investigation on the Bidirectional Cortical Neuroprosthetic System
for
Tetraplegia, Quadriplegia
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 65
Code: NCT03161067
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Genetic Analysis of Immune Disorders
for
DOK 8, STAT1, GATA2, Immunodeficiency, STAT3
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0 - 70+
Code: NCT00001467
Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Bethesda MD, Washington D.C. DC, Falls Church VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Fairfax VA, Baltimore MD, Charlottesville VA,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 70+
Code: NCT00923507
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase3, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Washington DC, Falls Church VA, Baltimore MD,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Columbia MD, Baltimore MD, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Annapolis MD, Columbus OH, Myrtle Beach SC, Boston MA,
Location: Bethesda MD, Takoma Park MD, Washington D.C. DC,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations